The new generation drug candidate molecules: Spectral, electrochemical, DNA-binding and anticancer activity properties

Yerel katalogda bu makaleye atıf yapan 15 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

1. 2019 The new metal-based compound from anticancer drug cytarabine: Spectral, electrochemical, DNA-binding, antiproliferative effect and in silico studiesAtıf 12 · OpenAlex
2. 2019 The new metal-based compound from anticancer drug cytarabine: Spectral, electrochemical, DNA-binding, antiproliferative effect and in silico studiesAtıf 12 · OpenAlex
3. 2019 The new metal-based compound from anticancer drug cytarabine: Spectral, electrochemical, DNA-binding, antiproliferative effect and in silico studiesAtıf 12 · OpenAlex
4. 2019 The new metal-based compound from anticancer drug cytarabine: Spectral, electrochemical, DNA-binding, antiproliferative effect and in silico studiesAtıf 12 · OpenAlex
5. 2026 Synthesis, spectroscopic, DNA/BSA, Molecular Docking, and DFT studies of pyridine bis-benzimidazole compounds containing cinnamyl groupsAtıf 3 · OpenAlex
6. 2026 Synthesis, spectroscopic, DNA/BSA, Molecular Docking, and DFT studies of pyridine bis-benzimidazole compounds containing cinnamyl groupsAtıf 3 · OpenAlex
7. 2026 Synthesis, spectroscopic, DNA/BSA, Molecular Docking, and DFT studies of pyridine bis-benzimidazole compounds containing cinnamyl groupsAtıf 3 · OpenAlex
8. 2026 Synthesis, spectroscopic, DNA/BSA, Molecular Docking, and DFT studies of pyridine bis-benzimidazole compounds containing cinnamyl groupsAtıf 3 · OpenAlex
9. 2024 New metal-based drugs: spectral, electrochemical, DNA-binding and anticancer activity propertiesAtıf 1 · OpenAlex
10. 2024 New metal-based drugs: spectral, electrochemical, DNA-binding and anticancer activity propertiesAtıf 1 · OpenAlex